Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention (Q62078702)
Jump to navigation
Jump to search
scientific article published on 4 January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention |
scientific article published on 4 January 2007 |
Statements
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention (English)
J Esteve
L Escoda
G MartÃn
V Rubio
J DÃaz-Mediavilla
M González
C Rivas
C Alvarez
J D González San Miguel
S Brunet
J F Tomás
M J Sayas
P Sánchez Godoy
P Bolufer
Spanish Cooperative Group PETHEMA
4 January 2007